Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


LUCI DAVID P Create: Alert

All | News | Filings
Date FiledTypeDescription
02/24/2023 4 LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.
Txns: Granted 130,000 options @ $3.41, valued at $443.3k
07/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2021 4 LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.
Txns: Bought 5,200 shares @ $4.8, valued at $25k
07/06/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/06/2021 4 LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.
Txns: Granted 350,000 options @ $6.26, valued at $2.2M
Granted 500,000 options @ $6.18, valued at $3.1M
06/24/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
08/22/2018 4 LUCI DAVID P (Director) has filed a Form 4 on AMERI Holdings, Inc.
Txns: Granted 150,000 options to buy @ $1.53, valued at $229.5k
Granted 15,000 restricted stock units @ $0
02/14/2018 3 LUCI DAVID P (Director) has filed a Form 3 on AMERI Holdings, Inc.
04/21/2017 4 LUCI DAVID P (Director) has filed a Form 4 on PLx Pharma Inc.
01/21/2016 4 LUCI DAVID P (President, CEO, Secretary) has filed a Form 4 on Dipexium Pharmaceuticals, Inc.
Txns: Granted 35,000 options @ $10.16, valued at $355.6k
01/29/2015 4 LUCI DAVID P (President, CEO, Secretary) has filed a Form 4 on Dipexium Pharmaceuticals, Inc.
Txns: Granted 35,000 options @ $11.35, valued at $397.3k
03/19/2014 4 LUCI DAVID P (President, CEO, Secretary) has filed a Form 4 on Dipexium Pharmaceuticals, Inc.
Txns: Bought 2,083 shares @ $12, valued at $25k
Granted 298,826 options to buy @ $13.93, valued at $4.2M
11/02/2009 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy